Veno-occlusive disease of the liver after allogeneic bone marrow transplantation for severe aplastic anemia

被引:16
作者
Lee, JH
Lee, KH
Choi, SJ
Min, YJ
Kim, JG
Kim, S
Lee, JS
Kim, SH
Park, CJ
Chi, HS
Kim, WK
机构
[1] Univ Ulsan, Coll Med, Dept Med, Asan Med Ctr,Songpa Ku, Seoul 138040, South Korea
[2] Univ Ulsan, Coll Med, Dept Clin Pathol, Asan Med Ctr, Seoul 138040, South Korea
关键词
VOD; allogeneic BMT; SAA;
D O I
10.1038/sj.bmt.1702583
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
There are few reports about the occurrence of hepatic VOD after BRIT for severe aplastic anemia (SAA). We prospectively studied 17 patients with SAA after allogeneic BMT for the occurrence and severity of VOD, Plasma levels of protein C, protein S, antithrombin UI, VWF, t-PA and PAI-1 were determined before preparative chemotherapy, on the day of marrow infusion, and on days 7, 14 and 21, VOD occurred in seven patients (41.2%) at a median of day 1 (range, day -2 to 15), Five had mild, and two moderate VOD, Platelet transfusion requirements were higher in the patients with VOD, The plasma levels of natural anticoagulants such as protein C, free protein S and antithrombin III decreased significantly on day 0 from the baseline levels. Plasma levels of t-PA, PAI-1 and VWF increased significantly in the early post-transplant period compared to the baseline levels. The mean plasma levels of t-PA on day 7 (P = 0.016) and PAI-1 on days 0 and 7 (P = 0.016, 0.032) were higher in the patients with VOD, In summary, we observed hypercoagulability and a high incidence of VOD after allogeneic BRIT for SAA, Levels of t-PA and PAI-1 were significantly higher in the patients with VOD after BMT.
引用
收藏
页码:657 / 662
页数:6
相关论文
共 26 条
[1]  
BAGLIN TP, 1994, BONE MARROW TRANSPL, V13, P1
[2]   THE SYNDROME OF HEPATIC VENOOCCLUSIVE DISEASE AFTER MARROW TRANSPLANTATION [J].
BEARMAN, SI .
BLOOD, 1995, 85 (11) :3005-3020
[3]   Related donor liner transplant for veno-occlusive disease following T-depleted unrelated donor bone marrow transplantation [J].
Bunin, N ;
Leahey, A ;
Dunn, S .
TRANSPLANTATION, 1996, 61 (04) :664-666
[4]  
CATANI L, 1993, BONE MARROW TRANSPL, V12, P253
[5]   CYCLOPHOSPHAMIDE RELATED HEPATOTOXICITY [J].
CLELAND, BD ;
POKORNY, CS .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1993, 23 (04) :408-408
[6]  
COLLINS PW, 1992, BONE MARROW TRANSPL, V10, P499
[7]   Cellular target of cyclophosphamide toxicity in the murine liver: Role of glutathione and site of metabolic activation [J].
DeLeve, LD ;
Wang, XD ;
Huybrechts, MM .
HEPATOLOGY, 1996, 24 (04) :830-837
[8]   CYCLOPHOSPHAMIDE-ASSOCIATED HEPATOTOXICITY [J].
GOLDBERG, JW ;
LIDSKY, MD .
SOUTHERN MEDICAL JOURNAL, 1985, 78 (02) :222-223
[9]  
GORDON B, 1991, BONE MARROW TRANSPL, V8, P497
[10]  
HARPER PL, 1990, BONE MARROW TRANSPL, V5, P39